Duff & Phelps Investment Management CO Novartis Ag Transaction History

Duff & Phelps Investment Management CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 16, 2019	SELL	$85.54 - $94.26 $1.88 Million - $2.08 Million	-22,021 Closed	0 $0
Q2 2019 Aug 02, 2019	SELL	$75.4 - $92.8 $2.8 Million - $3.45 Million	-37,129 Reduced 62.77%	22,021 $2.01 Million
Q1 2019 Apr 24, 2019	BUY	$75.32 - $86.15 $628,093 - $718,404	8,339 Added 16.41%	59,150 $5.69 Million
Q4 2018 Feb 04, 2019	BUY	$73.66 - $82.02 $3.74 Million - $4.17 Million	50,811 New	50,811 $4.36 Million

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Duff & Phelps Investment Management CO, based on Form 13F filings with the SEC.

Stay updated on Duff & Phelps Investment Management CO with notifications on news.